fda warning letter hims compounded semaglutide september 2025 issued 25 letters to telehealth companies for false and misleading claims about GLP-1 products. Unlike FDA-approved drugs, these products have not been proven to be safe, effective, or of RA/QA News Roll: Late September

176, E-138/A, Shastri Nagar opposite Metro Piller, New Delhi, Delhi 110065 Vendor Details Country of origin: India 750 MRP 773.443% off Save more with additional offers Get up to 75 cashback on a minimum order value (MOV) of 499 and above, valid once per customer

Melanotan 2 (also sold as tanning jabs, jabbatan or melanotan ii) is a counterfeit chemical of unknown origin which has never been formally tested in clinical trials and thus is sold, unlicensed, online

Understanding the Barrier to Receiving Weight Loss Injectables Our community members who are prescribed weight loss injectables containing the active ingredients semaglutide and tirzepatide have reported difficulties with consistently receiving their prescription

First, you have to be 18 years old or more (most people on Medicare are 65+)

According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025